Related Experiment Video

Updated: Jun 14, 2026

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse
04:14

In vivo Characterization of Endocrine Disrupting Chemical Effects via Thyroid Hormone Action Indicator Mouse

Published on: October 6, 2023

[Organ manifestations of hyperthyroidism]

R Hörmann1, P M Schumm-Draeger

  • 1Klinik für Allgemeine Innere Medizin, Endokrinologie und Gastroenterologie, Klinikum Lüdenscheid, Paulmannshöher Strasse 14, 58515, Lüdenscheid, Deutschland. rudolf.hoermann@gmail.com

Der Internist
|April 2, 2010
PubMed

Insights

Early diagnosis and treatment of hyperthyroidism are crucial, especially given its cardiovascular risks and subclinical onset. Recognizing diverse symptoms is key to managing this prevalent thyroid disorder.

Area of Science:

  • Endocrinology
  • Cardiovascular Medicine
  • Pathophysiology

Context:

  • Hyperthyroidism often presents with subtle symptoms, leading to delayed diagnosis and treatment.
  • Cardiovascular complications are the most serious and prevalent issue in hyperthyroid patients, increasing mortality.
  • Subclinical hyperthyroidism necessitates early intervention to prevent adverse outcomes.

Purpose:

  • To review the multifaceted impact of thyroid disorders on various organ systems.
  • To highlight the cardiovascular implications and increased mortality associated with hyperthyroidism.
  • To emphasize the importance of early diagnosis and treatment, even in subclinical stages.

Summary:

  • Thyroid hormones significantly influence multiple organs, and symptoms across systems should prompt suspicion of thyroid disease.
  • Cardiovascular disease is a major concern in hyperthyroidism, linked to higher mortality rates.
  • Research into selective thyroid hormone analogues offers future therapeutic potential.

Impact:

  • Increased awareness of hyperthyroidism's systemic effects and cardiovascular risks.
  • Promotes timely medical consultation and intervention for hyperthyroid patients.
  • Facilitates the development of targeted therapies for thyroid disorders.

More Related Videos

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model04:39

Generation of a Mouse Spontaneous Autoimmune Thyroiditis Model

Published on: March 17, 2023

Related Concept Videos

Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...